Elevate Capital Advisors’s CME Group CME Stock Holding History

Elevate Capital Advisors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,650	Closed	-$2.26M	–	81
2026 Q1	$2.26M	Sell	7,650 -2,050	-21%	-$609K	1.46%	23
2025 Q4	$2.65M	Buy	9,700 +1,181	+14%	+$321K	1.75%	20
2025 Q3	$2.3M	Buy	8,519 +3,919	+85%	+$1.07M	1.6%	26
2025 Q2	$1.27M	Sell	4,600 -808	-15%	-$220K	1.01%	49
2025 Q1	$1.43M	Sell	5,408 -289	-5%	-$71.3K	1.33%	38
2024 Q4	$1.32M	Buy	+5,697	New	+$1.31M	1.17%	37

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Elevate Capital Advisors's CME Position: Q2 2026 in Review

Elevate Capital Advisors sold out of CME Group (CME) in Q2 2026, closing a stake of 7,650 shares — an estimated $2.26M sold.

Elevate Capital Advisors first reported a position in CME in Q4 2024 and held it in 6 quarters. The position peaked at $2.65M in Q4 2025. 1,704 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Elevate Capital Advisors reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
Elevate Capital Advisors sold 7,650 CME Group shares in Q2 2026, an estimated $2.26M.
Elevate Capital Advisors first reported a position in CME Group in Q4 2024 and held it in 6 quarters.
Elevate Capital Advisors's CME Group position peaked at $2.65M in Q4 2025.
1,704 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Elevate Capital Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.